These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12551733)

  • 1. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?
    Akdeniz F; Taneli F; Noyan A; Yüncü Z; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):115-21. PubMed ID: 12551733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive function and risk for PCOS in women treated for bipolar disorder.
    Rasgon NL; Altshuler LL; Fairbanks L; Elman S; Bitran J; Labarca R; Saad M; Kupka R; Nolen WA; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich G; Grunze H; Walden J; Post R; Mintz J
    Bipolar Disord; 2005 Jun; 7(3):246-59. PubMed ID: 15898962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-associated reproductive hormone abnormalities: do bipolar men have the same risk as epileptic men?
    Aldemir E; Akdeniz F; Altay AB; Arıcı Ş; Umul M; Aydın HH; Çelebisoy M; Vahip S
    Turk Psikiyatri Derg; 2012; 23(4):223-7. PubMed ID: 23225122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis.
    Zhang L; Li H; Li S; Zou X
    Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():26-31. PubMed ID: 27160812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.
    Rasgon NL; Altshuler LL; Gudeman D; Burt VK; Tanavoli S; Hendrick V; Korenman S
    J Clin Psychiatry; 2000 Mar; 61(3):173-8. PubMed ID: 10817101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
    O'Donovan C; Kusumakar V; Graves GR; Bird DC
    J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive endocrine health in pubertal females with epilepsy on antiepileptic drugs: time to screen?
    Rauchenzauner M; Roscia S; Prieschl M; Wildt L; Haberlandt E; Baumann M; Rostasy K; Agostinelli S; Pizzolorusso A; Luef G; Verrotti A
    Neuropediatrics; 2014 Aug; 45(4):226-33. PubMed ID: 24407471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal evaluation of reproductive function in women treated for bipolar disorder.
    Rasgon NL; Reynolds MF; Elman S; Saad M; Frye MA; Bauer M; Altshuler LL
    J Affect Disord; 2005 Dec; 89(1-3):217-25. PubMed ID: 16171873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
    Joffe H; Cohen LS; Suppes T; McLaughlin WL; Lavori P; Adams JM; Hwang CH; Hall JE; Sachs GS
    Biol Psychiatry; 2006 Jun; 59(11):1078-86. PubMed ID: 16448626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
    Reynolds MF; Sisk EC; Rasgon NL
    Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.
    Morrell MJ; Isojärvi J; Taylor AE; Dam M; Ayala R; Gomez G; O'Neill F; Tennis P; Messenheimer J
    Epilepsy Res; 2003 May; 54(2-3):189-99. PubMed ID: 12837570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
    Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M
    Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate, bipolar disorder and polycystic ovarian syndrome.
    McIntyre RS; Mancini DA; McCann S; Srinivasan J; Kennedy SH
    Bipolar Disord; 2003 Feb; 5(1):28-35. PubMed ID: 12656935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
    Joffe H; Cohen LS; Suppes T; Hwang CH; Molay F; Adams JM; Sachs GS; Hall JE
    Biol Psychiatry; 2006 Dec; 60(12):1378-81. PubMed ID: 16950230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of valproate in metabolic disturbances in bipolar disorder patients.
    Chang HH; Yang YK; Gean PW; Huang HC; Chen PS; Lu RB
    J Affect Disord; 2010 Aug; 124(3):319-23. PubMed ID: 20060174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
    Isojarvi JI; Tapanainen JS
    Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV
    N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.